[EN] PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS [FR] HÉTÉROCYCLES BI- OU TRICYCLIQUES À ACTION PESTICIDE AVEC SUBSTITUANTS SOUFRÉS
[EN] PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS [FR] HÉTÉROCYCLES BI- OU TRICYCLIQUES À ACTION PESTICIDE AVEC SUBSTITUANTS SOUFRÉS
[EN] CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF<br/>[FR] MODULATEURS DE CALPAÏNE ET LEURS UTILISATIONS THÉRAPEUTIQUES
申请人:BLADE THERAPEUTICS INC
公开号:WO2019190885A1
公开(公告)日:2019-10-03
Small molecule calpain modulator compounds, including their pharmaceutically acceptable salts, can be included in pharmaceutical compositions. The compounds can be useful in inhibiting calpain, or competitive binding with calpastatin, by contacting them with CAPN1, CAPN2, and/or CAPN9 enzymes residing inside a subject. The compounds and composition can also be administered to a subject in order to treat a fibrotic disease or a secondary disease state or condition of a fibrotic disease.
The present invention is directed to compounds, compositions, and methods for halting or reversing the effects of chemoresistance in neoplastic diseases. In particular the use of hydroxylamines is described.
本发明涉及用于阻止或逆转肿瘤性疾病化疗耐药效应的化合物、组合物和方法。具体描述了羟胺的使用。
[EN] METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS<br/>[FR] MÉTHODES DE TRAITEMENT DE LA FIBROSE HÉPATIQUE À L'AIDE D'INHIBITEURS DE CALPAIN
申请人:BLADE THERAPEUTICS INC
公开号:WO2020006294A1
公开(公告)日:2020-01-02
Disclosed herein are methods of treating liver fibrosis by administering calpain inhibitors to subjects in need thereof.
本文披露了通过向需要的受试者施用卡尔佩因抑制剂来治疗肝纤维化的方法。
HYDROXYLAMINE COMPOUNDS AND METHODS OF THEIR USE
申请人:Patil Ghanshyam
公开号:US20080280890A1
公开(公告)日:2008-11-13
The present disclosure provides compounds that include hydroxylamines of formula I or II, pharmaceutical compositions, and methods for their use. The methods utilize hydroxylamine compounds and/or their pharmaceutical compositions for the treatment of angiogenesis, hepatitis, complement-mediated pathologies, drusen-mediated pathologies, macular degeneration and certain other ophthalmic conditions, inflammation, arthritis, and related diseases and for the inhibition of complement activation.
PESTICIDALLY ACTIVE BI- OR TRICYCLIC HETEROCYCLES WITH SULFUR CONTAINING SUBSTITUENTS
申请人:SYNGENTA PARTICIPATIONS AG
公开号:US20160255837A1
公开(公告)日:2016-09-08
Pesticidally active bi- or tricyclic heterocycles with sulphur-containing substituents, stereoisomers and tautomeric forms thereof that can be used as insecticides and can be prepared in a manner known per se.